45 results
DEFA14A
ACGN
Aceragen Inc
30 Sep 22
Additional proxy soliciting materials
4:18pm
-regulatory organization (including Nasdaq).
“Hazardous Materials” means any pollutant, chemical, substance and any toxic, infectious, carcinogenic
8-K
EX-2.1
0ncbqsci1j3l7bqd
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
DEFA14A
EX-99.2
zw5e9cj98kwiccg
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.2
9qyvxfrygv1cnu6c
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
8-K
EX-10.1
1xw f6vw7vrht
15 Jul 20
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
8:15am
8-K
EX-10.1
vt2oyof1w8goy9qv
7 Apr 20
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
4:30pm
8-K
EX-10.1
l06ekey rl0fi5vb
23 Dec 19
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million
4:01pm
8-K
EX-1.1
447bjo6 jgcfmon
26 Nov 18
Entry into a Material Definitive Agreement
5:25pm
425
EX-2.1
kp97juny
22 Jan 18
Business combination disclosure
12:00am
425
EX-2.1
e8xir2
22 Jan 18
Business combination disclosure
12:00am